GoodRx

GoodRx to Present at the Cowen 43rd Annual Health Care Conference

Retrieved on: 
Tuesday, February 21, 2023

GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Cowen 43rd Annual Health Care Conference in Boston, MA on Tuesday, March 7, 2023 at 6:50 a.m. Pacific Time (9:50 a.m. Eastern Time).

Key Points: 
  • GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Cowen 43rd Annual Health Care Conference in Boston, MA on Tuesday, March 7, 2023 at 6:50 a.m. Pacific Time (9:50 a.m. Eastern Time).
  • A live webcast of the presentation will be available on the Company's Investor Relations website, https://investors.goodrx.com/ .
  • Following the conference, an archived recording will be available on the Company’s website for at least 30 days.

GoodRx Response to FTC Settlement

Retrieved on: 
Wednesday, February 1, 2023

We are thoughtful and disciplined about what information we gather and how and why we use it.

Key Points: 
  • We are thoughtful and disciplined about what information we gather and how and why we use it.
  • The settlement with the FTC focuses on an old issue that was proactively addressed almost three years ago, before the FTC inquiry began.
  • Entering into the settlement allows us to avoid the time and expense of protracted litigation.
  • We believe that the requirements detailed in the settlement will have no material impact on our business or on our current or future operations.

GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call

Retrieved on: 
Tuesday, January 31, 2023

GoodRx Holdings Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023.

Key Points: 
  • GoodRx Holdings Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023.
  • GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company’s business outlook.
  • To access the conference call, please pre-register using this link .
  • The call will also be webcast live on the Company’s investor relations website at https://investors.goodrx.com , where accompanying materials will be posted prior to the conference call.

Prospera Welcomes Wellness Clinic

Retrieved on: 
Wednesday, January 25, 2023

"We are very excited to help people in their journey to become their best self," said Dr. Nikki Javit, co-founder of the clinic with her husband, Matt.

Key Points: 
  • "We are very excited to help people in their journey to become their best self," said Dr. Nikki Javit, co-founder of the clinic with her husband, Matt.
  • Nikki's passion for wellness can be heard weekly on The Peptide Podcast and within her posts as a contributor for GoodRx .
  • "Being established in Prospera gives BIFAT Clinic the ability to offer our products at highly competitive rates, which we are passing on to our clients.
  • Ultimately, it is a personal decision to take life-changing action," Matt said with a smile, referring to the clinic's website bifat.life .

E-Prescribing Market to Hit $19.28 Billion by 2030: Grand View Research, Inc

Retrieved on: 
Tuesday, January 24, 2023

On the other hand, improving healthcare infrastructure and increasing healthcare expenditure in developing countries are anticipated to provide numerous growth opportunities for the market.

Key Points: 
  • On the other hand, improving healthcare infrastructure and increasing healthcare expenditure in developing countries are anticipated to provide numerous growth opportunities for the market.
  • North America held a major market share of over 40% in 2022, owing to government initiatives and incentive programs.
  • Key players in the market are investing in the launch of new products and collaborations for sustaining the market.
  • Grand View Research has segmented the global e-prescribing market based on product, delivery mode, usage methods, substances, specialties, end-use, and region
    E-Prescribing Market - Product Outlook (Revenue, USD Million, 2017 - 2030)

E-Prescribing Market to Hit $19.28 Billion by 2030: Grand View Research, Inc

Retrieved on: 
Tuesday, January 24, 2023

On the other hand, improving healthcare infrastructure and increasing healthcare expenditure in developing countries are anticipated to provide numerous growth opportunities for the market.

Key Points: 
  • On the other hand, improving healthcare infrastructure and increasing healthcare expenditure in developing countries are anticipated to provide numerous growth opportunities for the market.
  • North America held a major market share of over 40% in 2022, owing to government initiatives and incentive programs.
  • Key players in the market are investing in the launch of new products and collaborations for sustaining the market.
  • Grand View Research has segmented the global e-prescribing market based on product, delivery mode, usage methods, substances, specialties, end-use, and region
    E-Prescribing Market - Product Outlook (Revenue, USD Million, 2017 - 2030)

SmartRx Represents the Newest in Prescription Discount Cards, With Premium Savings Options

Retrieved on: 
Thursday, January 12, 2023

Starting today, these consumers have access to SmartRx , the newest prescription discount card.

Key Points: 
  • Starting today, these consumers have access to SmartRx , the newest prescription discount card.
  • While designed to compete directly with GoodRx, SingleCare and Carecard, SmartRx (a division of Smarty ) acts as a premium health savings that goes beyond prescription drugs.
  • The SmartRx Discount Card helps consumers save up to 80% on their prescription drugs.
  • “SmartRx+ goes beyond prescription savings and offers a smart health care savings approach,” said Vipin Porwal, CEO and founder of Smarty and SmartRx.

AbacusNext Announces Key Executive Appointments to Advance Growth Initiatives

Retrieved on: 
Thursday, January 12, 2023

These latest additions round out the company’s executive team and demonstrate its dedication to taking professional services firms further with modern technology solutions.

Key Points: 
  • These latest additions round out the company’s executive team and demonstrate its dedication to taking professional services firms further with modern technology solutions.
  • Newly appointed CFO Moav comes to AbacusNext from GoodRx where he served as senior vice president of finance.
  • “We are thrilled to have such respected and industry-leading experts join our executive team,” states Keri Gohman, CEO of AbacusNext.
  • We are well poised for the future, and I look forward to all that we will accomplish together!”
    To learn more about the executive team at AbacusNext, visit https://www.abacusnext.com/leadership/ .